Reply by Authors

Affiliations

¹ Centre de recherche du Centre Hospitalier Universitaire de Québec-Université Laval (CHU de Québec Research Centre-UL), Centre de recherche en cancer (CRC) de l'Université Laval and Faculty of Pharmacy, Université Laval, Quebec City, Quebec, Canada.
² Statistical and Clinical Research Platform, CHU de Québec Research Centre-UL, Quebec City, Quebec, Canada.
³ CHU de Québec Research Centre-UL, CRC de l'Université Laval and Faculty of Medicine, Université Laval, Quebec City, Quebec, Canada.
⁴ McGill University Health Centre, Faculty of Medicine, McGill University, Montreal, Quebec, Canada.
⁵ Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montreal, Quebec, Canada.
⁶ Faculty of Medicine, Université de Sherbrooke, Quebec City, Quebec, Canada.
⁷ Canada Research Chair in Pharmacogenomics, Quebec City, Quebec, Canada.

Cylia Dahmani et al. J Urol. 2025 Mar.

. 2025 Mar;213(3):293-294.

doi: 10.1097/JU.0000000000004352. Epub 2024 Dec 17.

¹ Centre de recherche du Centre Hospitalier Universitaire de Québec-Université Laval (CHU de Québec Research Centre-UL), Centre de recherche en cancer (CRC) de l'Université Laval and Faculty of Pharmacy, Université Laval, Quebec City, Quebec, Canada.
² Statistical and Clinical Research Platform, CHU de Québec Research Centre-UL, Quebec City, Quebec, Canada.
³ CHU de Québec Research Centre-UL, CRC de l'Université Laval and Faculty of Medicine, Université Laval, Quebec City, Quebec, Canada.
⁴ McGill University Health Centre, Faculty of Medicine, McGill University, Montreal, Quebec, Canada.
⁵ Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montreal, Quebec, Canada.
⁶ Faculty of Medicine, Université de Sherbrooke, Quebec City, Quebec, Canada.
⁷ Canada Research Chair in Pharmacogenomics, Quebec City, Quebec, Canada.

No abstract available

LinkOut - more resources